Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ FGL1 Monoclonal Antibody (4F9C11)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA538522
Description
This antibody has been tested in indirect ELISA.
Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene.
Specifications
FGL1 | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
Q08830 | |
FGL1 | |
Purified recombinant fragment of human FGL1 (aa: 23-312) expressed in E. Coli. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG2a |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
4F9C11 | |
Unconjugated | |
FGL1 | |
Fgl1; fibrinogen like 1; fibrinogen-like 1; fibrinogen-like protein 1; Fibrinogen-related protein 1; fibronigen-like protein 1; Frep1; Hepassocin; hepatocellular carcinoma-related sequence; hepatocyte-derived fibrinogen-related protein 1; HFREP1; HFREP-1; HP-041; HPS; Lfire1; LFIRE-1; Liver fibrinogen-related protein 1; Liver fibrinogen-related protein-1; Mfire1; Mfire-1; Mfrep-1; MGC12455; OTTHUMP00000122468 | |
Mouse | |
Protein G | |
RUO | |
2267 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction